116 related articles for article (PubMed ID: 8912852)
1. Gangliosides expressed in human breast cancer.
Marquina G; Waki H; Fernandez LE; Kon K; Carr A; Valiente O; Perez R; Ando S
Cancer Res; 1996 Nov; 56(22):5165-71. PubMed ID: 8912852
[TBL] [Abstract][Full Text] [Related]
2. Detection of gangliosides as N-glycolylneuraminic acid-specific tumor-associated Hanganutziu-Deicher antigen in human retinoblastoma cells.
Higashi H; Sasabe T; Fukui Y; Maru M; Kato S
Jpn J Cancer Res; 1988 Aug; 79(8):952-6. PubMed ID: 2460424
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of 66-kDa glycoprotein from human breast carcinoma.
Feng R; Liu X; Guo Z; Li J
Cancer Sci; 2007 Sep; 98(9):1344-9. PubMed ID: 17640306
[TBL] [Abstract][Full Text] [Related]
4. CMP-N-Acetylneuraminic acid hydroxylase is exclusively inactive in humans.
Irie A; Suzuki A
Biochem Biophys Res Commun; 1998 Jul; 248(2):330-3. PubMed ID: 9675135
[TBL] [Abstract][Full Text] [Related]
5. Multi-dimensional role of gangliosides in modulating cancer hallmarks and their prospects in targeted cancer therapy.
Sarkar A; Banerjee S; Biswas K
Front Pharmacol; 2023; 14():1282572. PubMed ID: 38089042
[TBL] [Abstract][Full Text] [Related]
6. Cell Membrane Sialome: Sialic Acids as Therapeutic Targets and Regulators of Drug Resistance in Human Cancer Management.
Jastrząb P; Narejko K; Car H; Wielgat P
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894470
[TBL] [Abstract][Full Text] [Related]
7. Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment.
van der Haar Àvila I; Windhouwer B; van Vliet SJ
Cancer Metastasis Rev; 2023 Sep; 42(3):941-958. PubMed ID: 37266839
[TBL] [Abstract][Full Text] [Related]
8. The biological role and immunotherapy of gangliosides and GD3 synthase in cancers.
Cao S; Hu X; Ren S; Wang Y; Shao Y; Wu K; Yang Z; Yang W; He G; Li X
Front Cell Dev Biol; 2023; 11():1076862. PubMed ID: 36824365
[TBL] [Abstract][Full Text] [Related]
9. Current progress in the development of prophylactic and therapeutic vaccines.
Li T; Qian C; Gu Y; Zhang J; Li S; Xia N
Sci China Life Sci; 2023 Apr; 66(4):679-710. PubMed ID: 36469218
[TBL] [Abstract][Full Text] [Related]
10. SILAC-based quantitative proteomics and microscopy analysis of cancer cells treated with the
Bousquet PA; Manna D; Sandvik JA; Arntzen MØ; Moreno E; Sandvig K; Krengel U
Front Immunol; 2022; 13():994790. PubMed ID: 36439103
[TBL] [Abstract][Full Text] [Related]
11. N-glycolylated carbohydrates in nature.
Awofiranye AE; Dhar C; He P; Varki A; Koffas MAG; Linhardt RJ
Glycobiology; 2022 Oct; 32(11):921-932. PubMed ID: 35925816
[TBL] [Abstract][Full Text] [Related]
12. N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease.
Shewell LK; Day CJ; Kutasovic JR; Abrahams JL; Wang J; Poole J; Niland C; Ferguson K; Saunus JM; Lakhani SR; von Itzstein M; Paton JC; Paton AW; Jennings MP
BMC Cancer; 2022 Mar; 22(1):334. PubMed ID: 35346112
[TBL] [Abstract][Full Text] [Related]
13. VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patients.
Khan ANH; Emmons TR; Magner WJ; Alqassim E; Singel KL; Ricciuti J; Eng KH; Odunsi K; Tomasi TB; Lee K; Abrams SI; Mesa C; Segal BH
Cancer Immunol Immunother; 2022 Oct; 71(10):2355-2369. PubMed ID: 35166871
[TBL] [Abstract][Full Text] [Related]
14. Glycosphingolipids.
Chiricozzi E; Aureli M; Mauri L; Di Biase E; Lunghi G; Fazzari M; Valsecchi M; Carsana EV; Loberto N; Prinetti A; Sonnino S
Adv Exp Med Biol; 2021; 1325():61-102. PubMed ID: 34495530
[TBL] [Abstract][Full Text] [Related]
15. The Role of Sphingolipids in Cancer Immunotherapy.
Giussani P; Prinetti A; Tringali C
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204326
[TBL] [Abstract][Full Text] [Related]
16. Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy.
Groux-Degroote S; Delannoy P
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200284
[TBL] [Abstract][Full Text] [Related]
17. Sialic acid O-acetylation: From biosynthesis to roles in health and disease.
Visser EA; Moons SJ; Timmermans SBPE; de Jong H; Boltje TJ; Büll C
J Biol Chem; 2021 Aug; 297(2):100906. PubMed ID: 34157283
[TBL] [Abstract][Full Text] [Related]
18. Successive High-Resolution (H
Tian H; Sparvero LJ; Anthonymuthu TS; Sun WY; Amoscato AA; He RR; Bayır H; Kagan VE; Winograd N
Anal Chem; 2021 Jun; 93(23):8143-8151. PubMed ID: 34075742
[TBL] [Abstract][Full Text] [Related]
19. Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging.
Houvast RD; Vankemmelbeke M; Durrant LG; Wuhrer M; Baart VM; Kuppen PJK; de Geus-Oei LF; Vahrmeijer AL; Sier CFM
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33371487
[TBL] [Abstract][Full Text] [Related]
20. N-glycolyl chondroitin synthesis using metabolically engineered E. coli.
Awofiranye AE; Baytas SN; Xia K; Badri A; He W; Varki A; Koffas M; Linhardt RJ
AMB Express; 2020 Aug; 10(1):144. PubMed ID: 32803432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
